Search Results

The intra‐operative use of biological products: A multi‐centre regional patient perspective of a potential consenting conundrum.

• Authors : Jolly, Karan¹ (AUTHOR) ; Darr, Adnan² (AUTHOR); Aslanidou, Anastasia¹ (AUTHOR)

• Source: Clinical Otolaryngology. Sep2019, Vol. 44 Issue 5, p831-835. 5p.

Record details

Exploring engineered vesiculation by Pseudomonas putida KT2440 for natural product biosynthesis.

• Authors : Bitzenhofer NL; Institute of Molecular Enzyme Technology (IMET), Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Höfel C

Subjects: Pseudomonas putida*/Pseudomonas putida*/Pseudomonas putida*/genetics ; Pseudomonas putida*/Pseudomonas putida*/Pseudomonas putida*/metabolism ; Biological Products*/Biological Products*/Biological Products*/metabolism

• Source: Microbial biotechnology [Microb Biotechnol] 2024 Jan; Vol. 17 (1), pp. e14312. Date of Electronic Publication: 2023 Jul 12.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101316335 Publication Model: Print-Electronic Cited

Record details

A Novel Vortex Tube-Assisted Atmospheric Freeze-Drying System: Effect of Osmotic Pretreatment on Biological Products.

• Authors : Md Atiqure Rahman, S.¹; Enamul Hoque, M.² ; Rahman, Saidur³

Subjects: *FOOD dehydration; *FREEZE-drying; *BIOLOGICAL products

• Source: Journal of Food Process Engineering. Jun2017, Vol. 40 Issue 3, pn/a-N.PAG. 11p.

Record details

N-methyl-D-aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products.

• Authors : Chen YY; College of Life Sciences, Northwest University, Xi'an, China.; Xue Y

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Biological Products*

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 May; Vol. 29 (5), pp. 1290-1299. Date of Electronic Publication: 2023 Jan 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print-Electronic Cited

Record details

Accelerated CMC workflows to enable speed to clinic in the COVID-19 era: A multi-company view from the biopharmaceutical industry.

• Authors : Higgins MF; BioPhorum Development Group, London, United Kingdom.; Abu-Absi N

Subjects: Biological Products*/Biological Products*/Biological Products*/therapeutic use ; COVID-19*; Humans

• Source: Biotechnology progress [Biotechnol Prog] 2023 Mar; Vol. 39 (2), pp. e3321. Date of Electronic Publication: 2023 Jan 20.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8506292 Publication Model: Print-Electronic Cited

Record details

Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis.

• Authors : Taxonera C; Inflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Madrid, Spain.; Olivares D

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Biological Products*/Biological Products*/Biological Products*/therapeutic use; Humans

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 610-619. Date of Electronic Publication: 2023 Jan 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium:

Record details

Biopharmaceutical applications of α-galactosidases.

• Authors : Anisha GS; Post-Graduate and Research Department of Zoology, Government College for Women, Thiruvananthapuram, Kerala, India.

Subjects: Biological Products* ; Fabry Disease*; Humans

• Source: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2023 Feb; Vol. 70 (1), pp. 257-267. Date of Electronic Publication: 2022 Apr 25.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8609465 Publication Model: Print-Electronic Cited

Record details

Biobanking of human biological material and the principle of noncommercialisation of the human body and its parts.

• Authors : Pawlikowska, Joanna¹ ; Pawlikowski, Jakub^2,3; Krekora‐Zając, Dorota^3,4

• Source: Bioethics. Feb2023, Vol. 37 Issue 2, p154-164. 11p.

Record details

Progress in the development of naturally derived active metabolites-based drugs: Potential therapeutics for Alzheimer's disease.

• Authors : Mani R; Department of Biotechnology, School of Bioscience, Periyar University, Salem, Tamil Nadu, India.; Sha Sulthana A

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Plants, Medicinal*/Plants, Medicinal*/Plants, Medicinal*/metabolism ; Biological Products*/Biological Products*/Biological Products*/pharmacology

• Source: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2022 Dec; Vol. 69 (6), pp. 2713-2732. Date of Electronic Publication: 2022 Feb 08.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8609465 Publication Model: Print-Electronic Cited

Record details

Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists.

• Authors : Mahé E; Beauchet A ...

Subjects: Biological Products*/Biological Products*/Biological Products*/adverse effects ; Biological Products*/Biological Products*/Biological Products*/therapeutic use ; Dermatologic Agents*/Dermatologic Agents*/Dermatologic Agents*/adverse effects

• Source: Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15828. Date of Electronic Publication: 2022 Sep 22.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited

Record details